Temporary but increasingly durable Candace Stuart | December 08, 2014 | Cardiovascular Business | Heart FailurePatients awaiting heart transplants can continue on ventricular assist devices for longer periods now, thanks to smaller profile devices with improved functionality, the Boston Globe reports.New tech helping heart patientsSubscribe to Cardiovascular Business NewsEmail Address * Candace Stuart, Contributor Related ContentBioCardia raises $4.4 million in financing for its heart failure cell therapiesStar Trek star's family awarded $13M in heart failure malpractice caseFDA sees potential in new AI software for monitoring heart failure patientsFDA gives greenlight to new AI tool for managing heart failure patientsAmerican Heart Association takes on cardiac amyloidosis with new initiativeDiabetes drugs improve survival for patients with ‘broken hearts’ Around the webHealth Exec Former high-level health officials think out loud about HHS, FDA Radiology Business Rad tech society establishes scholarships in memory of 2 influential membersRadiology Business FDA clears RadNet's AI-powered breast arterial calcification solutionSubscribe to Cardiovascular Business NewsEmail Address * Subscribe to Cardiovascular Business NewsEmail Address *